Search Within

Renier J Brentjens

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (31)
  2. Meeting Abstract (23)
  3. Review (1)
Groups
  1. Adult Leukemia (55)
  2. Center for Hematologic Malignancies (55)
  3. Department of Medicine (55)
  4. GSK Faculty (55)
  5. Hematologic Malignancies Research (55)
  6. Hematologic Malignancies, Division of (55)

More Groups

People
  1. Terence Purdon (23)
  2. Hollie Pegram (19)
  3. Sarwish Rafiq (15)
  4. Jae Park (12)
  5. Isabelle Riviere (11)
  6. Kevin Curran (10)

More People

Years
  1. 2025 (1)
  2. 2022 (1)
  3. 2021 (4)
  4. 2020 (8)
  5. 2019 (4)
  6. 2018 (9)

More Years

Publications
  1. Blood (15)
  2. Molecular Therapy (5)
  3. Journal of Clinical Oncology (3)
  4. Bone Marrow Transplantation (2)
  5. Cancer Discovery (2)
  6. Cancer Research (2)

More Publications

Publishers
  1. American Society of Hematology (16)
  2. Nature Publishing Group (14)
  3. American Association for Cancer Research (6)
  4. American Society of Clinical Oncology (3)
  5. Cell Press (3)
  6. Elsevier Inc. (3)

More Publishers

Results (55)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Enhancing antitumor efficacy of chimeric antigen receptor T cells through constitutive CD40L expression
    Journal Article

    Curran, K. J.; Seinstra, B. A.; Nikhamin, Y.; Yeh, R.; Usachenko, Y.; van Leeuwen, D. G.; Purdon, T.; Pegram, H. J.; Brentjens, R. J.
    Molecular Therapy (2015)

    Fulltext@MSK | Save
  • IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia
    Journal Article

    Pegram, H. J.; Purdon, T. J.; van Leeuwen, D. G.; Curran, K. J.; Giralt, S. A.; Barker, J. N.; Brentjens, R. J.
    Leukemia (2015)

    Fulltext@MSK | Save
  • Graded potency of chimeric antigen receptor (CAR)-engineered T cells for cancer immunotherapy
    Meeting Abstract

    Sadelain, M.; Condomines, M.; Zhao, Z.; Brentjens, R. J.; Riviere, I.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Engineered T cell receptor-mimic antibody, (TCRm) chimeric antigen receptor (CAR) T cells against the intracellular protein Wilms tumor-1 (WT1) for treatment of hematologic and solid cancers
    Meeting Abstract

    Rafiq, S.; Dao, T.; Liu, C.; Scheinberg, D. A.; Brentjens, R. J.
    Blood (2014)

    Fulltext@MSK | Save
  • Blocking CD47 improves CAR T cell therapy
    Meeting Abstract

    Pegram, H. J.; Purdon, T. J.; Brentjens, R. J.
    Molecular Therapy (2014)

    Fulltext@MSK | Save
  • Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies
    Journal Article

    Davila, M. L.; Bouhassira, D.; Park, J. H.; Curran, K. J.; Smith, E.; Pegram, H. J.; Brentjens, R.
    International Journal of Hematology (2014)

    Fulltext@MSK | Save
  • CD28z CARs and armored CARs
    Journal Article

    Pegram, H. J.; Park, J. H.; Brentjens, R. J.
    The Cancer Journal (2014)

    Fulltext@MSK | Save
  • Chimeric antigen receptors for T cell immunotherapy: Current understanding and future directions
    Journal Article

    Curran, K. J.; Pegram, H. J.; Brentjens, R. J.
    Journal of Gene Medicine (2012)

    Fulltext@MSK | Save
  • Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
    Journal Article

    Pegram, H. J.; Lee, J. C.; Hayman, E. G.; Imperato, G. H.; Tedder, T. F.; Sadelain, M.; Brentjens, R. J.
    Blood (2012)

    Fulltext@MSK | Save
  • Tumor specific T cells modified to secrete IL-12 eradicate systemic tumors in the absence of prior toxic chemotherapy conditioning regimens
    Meeting Abstract

    Pegram, H. J.; Lee, J.; Hayman, E.; Imperato, G. H.; Tedder, T. J.; Brentjens, R. J.
    Blood (2011)

    Fulltext@MSK | Save